RTA compliance certificate under SEBI Reg 74(5) for Q2 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹143.90

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-0.7% vs market

Computers - Software & Consulting peers, median of 64sector+0.6%-0.6% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.6 pts less than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.7-0.7+0.6-0.6

Next day

+0.0-1.0+1.0+1.3-1.3

+0.0-0.3+0.3+2.6-2.6

—-1.9—+0.8—

+0.0-4.5+4.5+0.5-0.5

—-5.5—-1.3—

+0.0-7.3+7.3-3.7+3.7

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 64Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

iSera Lifesciences (formerly Covidh Technologies) submitted a compliance certificate from its Registrar and Share Transfer Agent, Skyline Financial Services, under SEBI Regulation 74(5) for the quarter and half year ended September 30, 2026. The RTA confirmed that no physical share certificates were received for dematerialisation of equity shares during the period. This is a standard quarterly regulatory filing required of all listed companies and carries no business or financial information.

Likely market impact

Routine regulatory compliance filing with no material impact on operations, financials, or shareholders.